drugset / Trial / NCT01108562

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

NCT01108562

RandomizedQuadruple-blindTreatment

Summary

This study will focus on patients undergoing total hip arthroplasty and Loma Linda University Medical Center \& East Campus. These patients will be randomized to receive a low dose lidocaine infusion or placebo, in addition to the patient controlled analgesia pump. These groups will be compared to one another statistically to determine which group shows the safest and most satisfying pain control.

Timeline

Start
2008-02
Primary completion
2008-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.33 mg/kg Intravenous

Indications

No indication recorded.